Cargando…

Surgery combined with adenoviral p53 gene therapy for treatment of non-small cell lung cancer: a phase II study

OBJECTIVE: To assess the efficacy of radical surgery combined with recombinant adenoviral human p53 (rAd-p53) gene therapy in treatment of resectable non-small cell lung cancer. METHOD: A total of 163 patients with resectable NSCLC meeting the inclusion criteria were randomly assigned to two groups:...

Descripción completa

Detalles Bibliográficos
Autores principales:	Deng, Bo, Sun, Tianyu, Tang, Bo, Tao, Shaolin, Kang, Poming, Qian, Kai, Jiang, Bin, Li, Kun, Li, Kunkun, Zhou, Jinghai, Wang, Ruwen, Tan, Qunyou
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5739798/ https://www.ncbi.nlm.nih.gov/pubmed/29291013 http://dx.doi.org/10.18632/oncotarget.22333

Ejemplares similares

The Human Positive Cofactor 4 is a Promising Chemotherapeutic Target in Lung Adenocarcinoma
por: Sun, Tianyu, et al.
Publicado: (2021)

Neoadjuvant immunotherapy combined with chemotherapy significantly improved patients’ overall survival when compared with neoadjuvant chemotherapy in non-small cell lung cancer: A cohort study
por: Dai, Fuqiang, et al.
Publicado: (2022)

Comparison of Sleeve Lobectomy for Lung Cancer Using Mini-Thoracotomy and an Optimized Robot-Assisted Technique
por: Shaolin, Tao, et al.
Publicado: (2021)

Genomic profiles and transcriptomic microenvironments in 2 patients with synchronous lung adenocarcinoma and lung squamous cell carcinoma: a case report
por: Wu, Licheng, et al.
Publicado: (2020)

CCR7 promote lymph node metastasis via regulating VEGF-C/D-R3 pathway in lung adenocarcinoma
por: Yu, Jie, et al.
Publicado: (2017)

High Expression of BCAR1 by Circulating Tumor Cells and Tumor Tissues Is Predictive of a Poor Prognosis of Early-Stage Lung Adenocarcinoma Potentially Due to Regulation of Epithelial-Mesenchymal Transition
por: Jiang, Shasha, et al.
Publicado: (2020)

Editorial: Adenoviral Infection and Immunity, and Adenoviral Vectors for Gene Therapy Applications
por: Zhang, Qiwei, et al.
Publicado: (2022)

Clinical utility of recombinant adenoviral human p53 gene therapy: current perspectives
por: Chen, Guang-xia, et al.
Publicado: (2014)

Efficacy of Recombinant Adenoviral Human p53 Gene in Treatment of Malignant Pleural or Peritoneal Effusions
por: ZHANG, Xin, et al.
Publicado: (2013)

Adenoviral Producer Cells
por: Kovesdi, Imre, et al.
Publicado: (2010)

Targeted adenoviral vectors
por: Vigne, E, et al.
Publicado: (2001)

Xenogenic Adenoviral Vectors
por: Mittal, Suresh K., et al.
Publicado: (2016)

Xenogenic Adenoviral Vectors
por: Both, Gerald W.
Publicado: (2002)

The miR-23a/27a/24-2 cluster promotes postoperative progression of early-stage non-small cell lung cancer
por: Fan, Xiaoqing, et al.
Publicado: (2021)

A p53-independent apoptotic mechanism of adenoviral mutant E1A was involved in its selective antitumor activity for human cancer
por: Fang, Lin, et al.
Publicado: (2016)

Discrimination of Kawasaki disease with concomitant adenoviral detection differentiating from isolated adenoviral infection
por: Kim, Jong Han, et al.
Publicado: (2018)

Poly(I:C)/Alum Mixed Adjuvant Priming Enhances HBV Subunit Vaccine-Induced Immunity in Mice When Combined with Recombinant Adenoviral-Based HBV Vaccine Boosting
por: Chuai, Xia, et al.
Publicado: (2013)

Pathogenesis and management of adenoviral keratoconjunctivitis
por: Chigbu, DeGaulle I, et al.
Publicado: (2018)

ADENOVIRAL VECTORS FOR PROTEIN EXPRESSION
por: Von Seggern, Dan J., et al.
Publicado: (1999)

Construction and application of adenoviral vectors
por: Zhang, Hongbo, et al.
Publicado: (2023)

Adenoviral Vector Driven by a Minimal Rad51 Promoter Is Selective for p53-Deficient Tumor Cells
por: Fong, Vincent, et al.
Publicado: (2011)

Analysis of Adenoviral p53 Gene Therapy Clinical Trials in Recurrent Head and Neck Squamous Cell Carcinoma
por: Sobol, Robert E., et al.
Publicado: (2021)

Acute Encephalopathy With Biphasic Seizures and Late Reduced Diffusion Associated With Adenoviral Pneumonia
por: Lee, Keun Soo, et al.
Publicado: (2019)

Using Multivalent Adenoviral Vectors for HIV Vaccination
por: Gu, Linlin, et al.
Publicado: (2013)

Adenoviral Targeting of Gene Expression to Tumors
por: Hogg, Richard T., et al.
Publicado: (2010)

Factors influencing adenoviral gene transfer
por: Huizinga, TWJ, et al.
Publicado: (2001)

Analysis of adenoviral attachment to human platelets
por: Shimony, Nilly, et al.
Publicado: (2009)

Adenoviral Vectors for Hemophilia Gene Therapy
por: Brunetti-Pierri, N, et al.
Publicado: (2013)

The Role of Chromatin in Adenoviral Vector Function
por: Wong, Carmen M., et al.
Publicado: (2013)

Progress in Adenoviral Capsid-Display Vaccines
por: Vujadinovic, Marija, et al.
Publicado: (2018)

Use of adenoviral vectors as veterinary vaccines
por: Ferreira, T B, et al.
Publicado: (2005)

Management of Adenoviral Keratoconjunctivitis: Challenges and Solutions
por: Labib, Bisant A, et al.
Publicado: (2020)

Immunology of Adenoviral Vectors in Cancer Therapy
por: Shaw, Amanda Rosewell, et al.
Publicado: (2019)

Adenoviral Vector Vaccines Antigen Transgene
por: Ertl, Hildegund C.J.
Publicado: (2016)

Molecular Epidemiology of Adenoviral Keratoconjunctivitis in Korea
por: Seo, Jeong-Won, et al.
Publicado: (2022)

A phase I study of an adenoviral vector delivering a MUC1/CD40-ligand fusion protein in patients with advanced adenocarcinoma
por: Tan, Tira J., et al.
Publicado: (2022)

Hypoxemia is an independent predictor of bronchiolitis obliterans following respiratory adenoviral infection in children
por: Wu, Pei-Qiong, et al.
Publicado: (2016)

Development of SiC Nanoparticles and Second Phases Synergistically Reinforced Mg-Based Composites Processed by Multi-Pass Forging with Varying Temperatures
por: Nie, Kaibo, et al.
Publicado: (2018)

Controlling the degrees of freedom in metasurface designs for multi-functional optical devices
por: Xiong, Bo, et al.
Publicado: (2019)

Small-size recombinant adenoviral hexon protein fragments for the production of virus-type specific antibodies
por: Pacesa, Martin, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_jse0ae64bjsekjrq8pdbmd7n5f